Hilltop National Bank Makes New $1.42 Million Investment in UnitedHealth Group Incorporated $UNH

Hilltop National Bank bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,551 shares of the healthcare conglomerate's stock, valued at approximately $1,420,000.

Several other hedge funds have also modified their holdings of UNH. Nuveen LLC acquired a new stake in shares of UnitedHealth Group in the first quarter worth approximately $3,846,764,000. Vanguard Group Inc. boosted its position in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP raised its holdings in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after buying an additional 2,486,839 shares during the period. National Bank of Canada FI raised its holdings in UnitedHealth Group by 137.8% in the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock valued at $859,518,000 after buying an additional 950,928 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in UnitedHealth Group by 13.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock valued at $3,702,736,000 after buying an additional 847,054 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research reports. KeyCorp cut their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Sanford C. Bernstein raised their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a report on Friday, September 5th. Oppenheimer dropped their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Finally, Piper Sandler dropped their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Stock Up 1.4%

Shares of NYSE:UNH opened at $353.26 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a fifty day simple moving average of $306.25 and a 200 day simple moving average of $356.57. The firm has a market cap of $319.94 billion, a PE ratio of 15.31, a price-to-earnings-growth ratio of 2.27 and a beta of 0.47. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.